Design Pharmaceuticals
Cambridge, US · Founded 2018 · Delaware corporation
Biotech
Founders & leadership
OC
Olivier ClytiDirector
JH
John HastewellDirector
DL
Dirk LoeffertExecutive Officer, Director
RN
Rob NicolExecutive Officer, Director
FD
Fred DomDirector
Reported raises · per SEC filings
Form D private placements▶$3MraisedFeb 2022 · 1 investors · BiotechnologyRule 506(b)
Officers, directors & promoters on the filing
- Olivier ClytiDirector
- John HastewellDirector
- Dirk LoeffertExecutive Officer, Director
- Rob NicolExecutive Officer, Director
- Fred DomDirector
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.